{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:56:00Z","timestamp":1786449360426,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is increasing evidence of a higher risk and poorer prognosis of cervical cancer among women with diabetes mellitus (DM) compared to the general population. These are mediated by higher susceptibility to persistent high-risk human papillomavirus (hr-HPV) infection due to dysfunctional clearance in an immunocompromised state. We aimed to determine the prevalence of hr-HPV infection and cervical lesions in a cohort of women with DM in Ghana. We further disaggregated the prevalence according to DM type and explored factors associated with hr-HPV infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective descriptive cross-sectional study assessed 198 women with DM who underwent cervical screening via concurrent hr-HPV DNA testing and visual inspection with acetic acid in an outpatient department of the National Diabetes Management and Research Centre in Korle-Bu Teaching Hospital, Accra from March to May 2022. Univariate and multivariable binary logistic regression were used to explore factors associated with hr-HPV positivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 198 women with DM (mean age, 60.2\u2009\u00b1\u200912.1 years), the overall hr-HPV prevalence rate was 21.7% (95% CI, 16.1\u201328.1), disaggregated as 1.5% (95% CI, 0.3\u20134.4) each for HPV16 and HPV18 and 20.7% (95% CI, 15.3\u201327.0) for <jats:italic>other<\/jats:italic> HPV genotype(s). Respective hr-HPV prevalence rates were 37.5% (95% CI, 15.2\u201364.6) for type 1 DM, 19.8% (95% CI, 13.9\u201326.7) for type 2 DM, and 25.0% (95% CI, 8.7\u201349.1) for unspecified\/other DM types. Past use of the combined contraceptive pill independently increased the risk of hr-HPV infection by approximately three times (adjusted odds ratio [aOR]\u2009=\u20092.98; 95% CI, 1.03\u2009\u2212\u20098.64; <jats:italic>p<\/jats:italic>-value\u2009=\u20090.045), whereas each unit increase in FBG level increased the odds of hr-HPV infection by about 15% (aOR\u2009=\u20091.15; 95% CI, 1.02\u2009\u2212\u20091.30; <jats:italic>p<\/jats:italic>-value\u2009=\u20090.021).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study points to a high prevalence of hr-HPV among women with DM and highlights a need for glycemic control among them as this could contribute to lowering their odds of hr-HPV infection. The low overall rates of HPV vaccination and prior screening also indicate a need to build capacity and expand the scope of education and services offered to women with DM as regards cervical precancer screening.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-024-03078-z","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T10:02:19Z","timestamp":1714039339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana"],"prefix":"10.1186","volume":"24","author":[{"given":"Yacoba","family":"Atiase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi","family":"Effah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Comfort","family":"Mawusi Wormenor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel","family":"Tekpor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esu","family":"Aku Catherine Morkli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice","family":"Boafo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Yorke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Aryee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana Owusu Mensah","family":"Essel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Danyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyram","family":"Kemawor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Akpalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"3078_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3078_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"3078_CR3","first-page":"319","volume":"19","author":"AD Shrestha","year":"2018","unstructured":"Shrestha AD, Neupane D, Vedsted P, Kallestrup P. Cervical Cancer prevalence, incidence and mortality in Low and Middle Income countries: a systematic review. Asian Pac J Cancer Prev. 2018;19:319\u201324.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3078_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.11604\/pamj.2019.34.44.19471","volume":"34","author":"AA Gyamfua","year":"2019","unstructured":"Gyamfua AA, Nkrumah I, Ibitoye BM, Agyemang BA, Ofosu ES, Tsoka-Gwegweni JM, et al. The level of knowledge and associated socio-demographic factors on cervical cancer among women: a cross-sectional study at Kenyase Bosore community, Ghana. Pan Afr Med J. 2019;34:44.","journal-title":"Pan Afr Med J"},{"key":"3078_CR5","doi-asserted-by":"publisher","first-page":"ed123","DOI":"10.3332\/ecancer.2022.ed123","volume":"16","author":"K Effah","year":"2022","unstructured":"Effah K, Tekpor E, Wormenor CM, Atuguba BH, Gedzah I, Amuah JE, et al. A revolution in cervical cancer prevention in Ghana. Ecancermedicalscience. 2022;16:ed123.","journal-title":"Ecancermedicalscience"},{"key":"3078_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.diabet.2011.09.007","volume":"38","author":"MA Martinez-Huedo","year":"2012","unstructured":"Martinez-Huedo MA, Lopez de Andres A, Hernandez-Barrera V, Carrasco-Garrido P, Martinez Hernandez D, Jim\u00e9nez-Garcia R. Adherence to breast and cervical cancer screening in Spanish women with diabetes: Associated factors and trend between 2006 and 2010. Diabetes Metab. 2012;38:142\u20138.","journal-title":"Diabetes Metab"},{"key":"3078_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11892-014-0535-8","volume":"14","author":"B Carstensen","year":"2014","unstructured":"Carstensen B, J\u00f8rgensen ME, Friis S. The epidemiology of diabetes and Cancer. Curr Diab Rep. 2014;14:535.","journal-title":"Curr Diab Rep"},{"key":"3078_CR8","doi-asserted-by":"publisher","first-page":"g7607","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JPA. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607.","journal-title":"BMJ"},{"key":"3078_CR9","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1515\/cclm-2017-0982","volume":"56","author":"E Anastasi","year":"2018","unstructured":"Anastasi E, Filardi T, Tartaglione S, Lenzi A, Angeloni A, Morano S. Linking type 2 diabetes and gynecological cancer: an introductory overview. Clin Chem Lab Med. 2018;56:1413\u201325.","journal-title":"Clin Chem Lab Med"},{"key":"3078_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1634\/theoncologist.2015-0111","volume":"20","author":"H-Y Kuo","year":"2015","unstructured":"Kuo H-Y, Lin Z-Z, Kuo R, Shau W-Y, Lai C-L, Yang Y-Y, et al. The prognostic impact of type 2 diabetes Mellitus on Early Cervical Cancer in Asia. Oncologist. 2015;20:1051\u20137.","journal-title":"Oncologist"},{"key":"3078_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41598-018-37694-1","volume":"9","author":"SW Gillani","year":"2019","unstructured":"Gillani SW, Zaghloul HA, Ansari IA, Abdul MIM, Sulaiman SAS, Baig MR, et al. Multivariate analysis on the effects of Diabetes and related clinical parameters on Cervical Cancer Survival Probability. Sci Rep. 2019;9:1084.","journal-title":"Sci Rep"},{"key":"3078_CR12","doi-asserted-by":"publisher","first-page":"e7981","DOI":"10.1097\/MD.0000000000007981","volume":"96","author":"S Chen","year":"2017","unstructured":"Chen S, Tao M, Zhao L, Zhang X. The association between diabetes\/hyperglycemia and the prognosis of cervical cancer patients. Medicine. 2017;96:e7981.","journal-title":"Medicine"},{"key":"3078_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3802\/jgo.2010.21.3.174","volume":"21","author":"SW Lee","year":"2010","unstructured":"Lee SW, Lee SY, Lee SR, Ju W, Kim SC. Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia. J Gynecol Oncol. 2010;21:174.","journal-title":"J Gynecol Oncol"},{"key":"3078_CR14","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","volume":"33","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, et al. Diabetes and Cancer. Diabetes Care. 2010;33:1674\u201385.","journal-title":"Diabetes Care"},{"key":"3078_CR15","first-page":"442","volume":"16","author":"A Berbudi","year":"2020","unstructured":"Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the Immune System. Curr Diabetes Rev. 2020;16:442\u20139.","journal-title":"Curr Diabetes Rev"},{"key":"3078_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2174\/15748863113086660071","volume":"8","author":"J Starup-Linde","year":"2013","unstructured":"Starup-Linde J, Karlstad \u00d8, Eriksen S, Vestergaard P, Bronsveld H, Vries F, et al. CARING (CAncer risk and INsulin analoGues): the Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - a Systematic Review and a Meta-analysis. Curr Drug Saf. 2013;8:296\u2013332.","journal-title":"Curr Drug Saf"},{"key":"3078_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S2213-8587(15)00379-4","volume":"4","author":"J Pearson-Stuttard","year":"2016","unstructured":"Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J. Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol. 2016;4:148\u201358.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3078_CR18","first-page":"771","volume":"79","author":"M Navarro-Meza","year":"2011","unstructured":"Navarro-Meza M, Martinez-Rivera MG, Santoyo-Telles F, Pita-L\u00f3pez ML. [Glucose, body mass index and pre-neoplastic lesions in the cervix]. Ginecol Obstet Mex. 2011;79:771\u20138.","journal-title":"Ginecol Obstet Mex"},{"key":"3078_CR19","doi-asserted-by":"publisher","first-page":"972963","DOI":"10.3389\/fendo.2022.972963","volume":"13","author":"C Yue","year":"2022","unstructured":"Yue C, Zhang C, Ying C, Jiang H. Diabetes associated with HPV infection in women aged over 50 years: a cross-sectional study from China\u2019s largest academic woman\u2019s hospital. Front Endocrinol (Lausanne). 2022;13:972963.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3078_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/13685538.2019.1582621","volume":"22","author":"S Hamid","year":"2019","unstructured":"Hamid S, Groot W, Pavlova M. Trends in cardiovascular diseases and associated risks in sub-saharan Africa: a review of the evidence for Ghana, Nigeria, South Africa, Sudan and Tanzania. Aging Male. 2019;22:169\u201376.","journal-title":"Aging Male"},{"key":"3078_CR21","unstructured":"mPharma. Ghana. The 10,000 Women Initiative. https:\/\/wellness.mpharma.com\/hpv. Accessed 24 Jul 2023."},{"key":"3078_CR22","unstructured":"Sansure Biotech. Sansure Biotech MA-6000 PCR System-Final | Enhanced Reader. https:\/\/www.sansureglobal.com\/product\/ma-6000-real-time-quantitative-thermal-cycler\/. Accessed 6 June 2023."},{"key":"3078_CR23","doi-asserted-by":"publisher","first-page":"114709","DOI":"10.1016\/j.jviromet.2023.114709","volume":"2023","author":"K Effah","year":"2023","unstructured":"Effah K, Agbemafle I, Essel NO, Amuah JE, Kotey EN, Antwi-Boasiako E, et al. Comparison of the AmpFire and MA-6000 polymerase chain reaction platforms for high-risk human papillomavirus testing in cervical precancer screening. J Virol Methods. 2023;2023:114709.","journal-title":"J Virol Methods"},{"key":"3078_CR24","first-page":"71","volume":"42","author":"AB Domfeh","year":"2008","unstructured":"Domfeh AB, Wiredu EK, Adjei AA, Ayeh-Kumi PFK, Adiku TK, Tettey Y, et al. Cervical human papillomavirus infection in Accra, Ghana. Ghana Med J. 2008;42:71\u20138.","journal-title":"Ghana Med J"},{"key":"3078_CR25","doi-asserted-by":"publisher","first-page":"e0001830","DOI":"10.1371\/journal.pgph.0001830","volume":"3","author":"K Effah","year":"2023","unstructured":"Effah K, Tekpor E, Wormenor CM, Amuah JE, Essel NO, Atuguba BH, et al. Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: a practical approach from Battor, Ghana. PLOS Glob Public Health. 2023;3:e0001830.","journal-title":"PLOS Glob Public Health"},{"key":"3078_CR26","doi-asserted-by":"publisher","first-page":"e0218762","DOI":"10.1371\/journal.pone.0218762","volume":"14","author":"A Krings","year":"2019","unstructured":"Krings A, Dunyo P, Pesic A, Tetteh S, Hansen B, Gedzah I, et al. Characterization of human papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana. PLoS ONE. 2019;14:e0218762.","journal-title":"PLoS ONE"},{"key":"3078_CR27","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1111\/cas.14997","volume":"112","author":"Y Watanabe","year":"2021","unstructured":"Watanabe Y, Katagiri R, Goto A, Shimazu T, Yamaji T, Sawada N, et al. Dietary glycemic index, glycemic load, and endometrial cancer risk: the Japan Public Health Center-based prospective study. Cancer Sci. 2021;112:3682\u201390.","journal-title":"Cancer Sci"},{"key":"3078_CR28","doi-asserted-by":"publisher","first-page":"118603","DOI":"10.1016\/j.lfs.2020.118603","volume":"264","author":"M Ghanavat","year":"2021","unstructured":"Ghanavat M, Shahrouzian M, Deris Zayeri Z, Banihashemi S, Kazemi SM, Saki N. Digging deeper through glucose metabolism and its regulators in cancer and metastasis. Life Sci. 2021;264:118603.","journal-title":"Life Sci"},{"key":"3078_CR29","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/EDE.0000000000000374","volume":"26","author":"A Amadou","year":"2015","unstructured":"Amadou A, Degoul J, Hainaut P, Chajes V, Biessy C, Torres Mejia G, et al. Dietary carbohydrate, Glycemic Index, Glycemic load, and breast Cancer risk among Mexican Women. Epidemiology. 2015;26:917\u201324.","journal-title":"Epidemiology"},{"issue":"Suppl 2","key":"3078_CR30","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.2967\/jnumed.107.047258","volume":"49","author":"RJ Gillies","year":"2008","unstructured":"Gillies RJ, Robey I, Gatenby RA. Causes and consequences of increased glucose metabolism of cancers. J Nucl Med. 2008;49(Suppl 2):S24\u201342.","journal-title":"J Nucl Med"},{"key":"3078_CR31","doi-asserted-by":"publisher","first-page":"e30494","DOI":"10.1097\/MD.0000000000030494","volume":"101","author":"J Zhou","year":"2022","unstructured":"Zhou J, Wei XC, Xu HY, Hu HB, Li FX, Zhou WJ, et al. Blood glucose levels and the risk of HPV multiple infections in high-grade squamous intraepithelial lesions: a retrospective cross-sectional study of Chinese patients. Medicine. 2022;101:e30494.","journal-title":"Medicine"},{"key":"3078_CR32","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/ijc.33365","volume":"148","author":"K Reinholdt","year":"2021","unstructured":"Reinholdt K, Thomsen LT, Munk C, Dehlendorff C, Aalborg GL, Carstensen B, et al. Incidence of human papillomavirus-related anogenital precancer and cancer in women with diabetes: a nationwide registry\u2010based cohort study. Int J Cancer. 2021;148:2090\u2013101.","journal-title":"Int J Cancer"},{"key":"3078_CR33","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3390\/v13071342","volume":"13","author":"M Kim","year":"2021","unstructured":"Kim M, Park NJ-Y, Jeong JY, Park JY. Multiple human papilloma virus (HPV) infections are Associated with HSIL and Persistent HPV infection status in Korean patients. Viruses. 2021;13:1342.","journal-title":"Viruses"},{"key":"3078_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41574-020-0329-9","volume":"16","author":"BD Hopkins","year":"2020","unstructured":"Hopkins BD, Goncalves MD, Cantley LC. Insulin\u2013PI3K signalling: an evolutionarily insulated metabolic driver of cancer. Nat Rev Endocrinol. 2020;16:276\u201383.","journal-title":"Nat Rev Endocrinol"},{"key":"3078_CR35","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ygyno.2014.10.011","volume":"135","author":"T Febbraro","year":"2014","unstructured":"Febbraro T, Lengyel E, Romero IL. Old drug, new trick: repurposing metformin for gynecologic cancers? Gynecol Oncol. 2014;135:614\u201321.","journal-title":"Gynecol Oncol"},{"key":"3078_CR36","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1111\/codi.15860","volume":"23","author":"AT Hsu","year":"2021","unstructured":"Hsu AT, Hung Y, Fang SH, D\u2019Adamo CR, Mavanur AA, Svoboda SM, et al. Metformin use and the risk of anal intraepithelial neoplasia in type II diabetic patients. Colorectal Dis. 2021;23:3220\u20136.","journal-title":"Colorectal Dis"},{"key":"3078_CR37","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.3390\/cancers13112545","volume":"13","author":"Y-H Chen","year":"2021","unstructured":"Chen Y-H, Wang P-H, Chen P-N, Yang S-F, Hsiao Y-H. Molecular and Cellular mechanisms of Metformin in Cervical Cancer. Cancers (Basel). 2021;13:2545.","journal-title":"Cancers (Basel)"},{"key":"3078_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13046-020-01627-6","volume":"39","author":"C Xia","year":"2020","unstructured":"Xia C, Liu C, He Z, Cai Y, Chen J. Metformin inhibits cervical cancer cell proliferation by modulating PI3K\/Akt-induced major histocompatibility complex class I-related chain A gene expression. J Exp Clin Cancer Res. 2020;39:127.","journal-title":"J Exp Clin Cancer Res"},{"key":"3078_CR39","doi-asserted-by":"publisher","first-page":"e7981","DOI":"10.1097\/MD.0000000000007981","volume":"96","author":"S Chen","year":"2017","unstructured":"Chen S, Tao M, Zhao L, Zhang X. The association between diabetes\/hyperglycemia and the prognosis of cervical cancer patients. Med (Baltim). 2017;96:e7981.","journal-title":"Med (Baltim)"},{"key":"3078_CR40","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1158\/1055-9965.EPI-15-1008","volume":"25","author":"K Han","year":"2016","unstructured":"Han K, Pintilie M, Lipscombe LL, Lega IC, Milosevic MF, Fyles AW. Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes. Cancer Epidemiol Biomarkers Prev. 2016;25:507\u201312.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3078_CR41","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/humupd\/dmq022","volume":"16","author":"D Cibula","year":"2010","unstructured":"Cibula D, Gompel A, Mueck AO, La Vecchia C, Hannaford PC, Skouby SO, et al. Hormonal contraception and risk of cancer. Hum Reprod Update. 2010;16:631\u201350.","journal-title":"Hum Reprod Update"},{"key":"3078_CR42","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1002\/ijc.25628","volume":"128","author":"M Marks","year":"2011","unstructured":"Marks M, Gravitt PE, Gupta SB, Liaw K-L, Kim E, Tadesse A, et al. The association of hormonal contraceptive use and HPV prevalence. Int J Cancer. 2011;128:2962\u201370.","journal-title":"Int J Cancer"},{"key":"3078_CR43","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for Medical Research Involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03078-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-024-03078-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03078-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T11:01:45Z","timestamp":1714042905000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-024-03078-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3078"],"URL":"https:\/\/doi.org\/10.1186\/s12905-024-03078-z","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"28 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was given by the Scientific and Technical Committee\/Institutional Review Board of the Korle-Bu Teaching Hospital (approval no. KBTH-STC\/IRB\/000175\/2022)\u00a0and the Ethical Review Committee of the Catholic Hospital Battor (approval no. CHB-ERC 0120\/06\/22). All study participants provided verbal informed consent before questionnaire administration, cervical sample collection, and visual inspection procedures. The study complied with the Helsinki Declaration [] on human experimentation, no one was below 16 years of age.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}